(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 3.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Stevanato Group Spa's revenue in 2026 is $1,413,178,777.On average, 13 Wall Street analysts forecast STVN's revenue for 2026 to be $393,998,139,336, with the lowest STVN revenue forecast at $374,616,217,032, and the highest STVN revenue forecast at $407,928,895,992. On average, 13 Wall Street analysts forecast STVN's revenue for 2027 to be $432,156,298,872, with the lowest STVN revenue forecast at $409,745,951,208, and the highest STVN revenue forecast at $452,749,591,320.
In 2028, STVN is forecast to generate $472,737,198,696 in revenue, with the lowest revenue forecast at $445,784,212,992 and the highest revenue forecast at $502,415,767,224.